Ventyx Biosciences Inc.

1.01
-0.05 (-4.72%)
At close: Apr 03, 2025, 3:59 PM
1.04
2.04%
Pre-market: Apr 04, 2025, 07:01 AM EDT

Ventyx Biosciences Statistics

Share Statistics

Ventyx Biosciences has 71.13M shares outstanding. The number of shares has increased by 0.89% in one year.

Shares Outstanding 71.13M
Shares Change (YoY) 0.89%
Shares Change (QoQ) 0.59%
Owned by Institutions (%) 77.05%
Shares Floating 61.17M
Failed to Deliver (FTD) Shares 6.23K
FTD / Avg. Volume 0.51%

Short Selling Information

The latest short interest is 6.68M, so 9.45% of the outstanding shares have been sold short.

Short Interest 6.68M
Short % of Shares Out 9.45%
Short % of Float 12.63%
Short Ratio (days to cover) 3.5

Valuation Ratios

The PE ratio is -1.11 and the forward PE ratio is -0.91. Ventyx Biosciences's PEG ratio is 0.03.

PE Ratio -1.11
Forward PE -0.91
PS Ratio 0
Forward PS 0.2
PB Ratio 0.59
P/FCF Ratio -1.14
PEG Ratio 0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ventyx Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.97, with a Debt / Equity ratio of 0.04.

Current Ratio 17.97
Quick Ratio 17.97
Debt / Equity 0.04
Debt / EBITDA -0.07
Debt / FCF -0.08
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.71M
Employee Count 79
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -79.39% in the last 52 weeks. The beta is 0.75, so Ventyx Biosciences's price volatility has been higher than the market average.

Beta 0.75
52-Week Price Change -79.39%
50-Day Moving Average 1.56
200-Day Moving Average 2.1
Relative Strength Index (RSI) 20.63
Average Volume (20 Days) 1.23M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -148.45M
Net Income -135.12M
EBITDA -148.45M
EBIT n/a
Earnings Per Share (EPS) -1.97
Full Income Statement

Balance Sheet

The company has 27.26M in cash and 10.79M in debt, giving a net cash position of 16.47M.

Cash & Cash Equivalents 27.26M
Total Debt 10.79M
Net Cash 16.47M
Retained Earnings -554.31M
Total Assets 276.56M
Working Capital 216.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -130.87M and capital expenditures -241K, giving a free cash flow of -131.11M.

Operating Cash Flow -130.87M
Capital Expenditures -241K
Free Cash Flow -131.11M
FCF Per Share -1.91
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VTYX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for VTYX is $11, which is 989.1% higher than the current price. The consensus rating is "Buy".

Price Target $11
Price Target Difference 989.1%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score -1.55
Piotroski F-Score 2